Operator Safety Zone During the Nitric Oxide Inhalation Vasoreactivity Test for Pulmonary Hypertension Patients-Reference-Cited by-同舟云学术

Operator Safety Zone During the Nitric Oxide Inhalation Vasoreactivity Test for Pulmonary Hypertension Patients

Published:2017 Issue:0 Volume:6 Page:88-94
ISSN:2187-5219
Container-title:Advanced Biomedical Engineering
language:en
Short-container-title:ABE

Author:

Hashimoto Kanae¹,Hashimoto Akiyoshi²,Kishimoto Masumi¹,Sugawara Kosuke¹,Funahashi Hitomi¹,Nakano Kota¹,Takahashi Hirohito¹,Hashimoto Syuichi¹,Miura Tetsuji²,Tsuchihashi Kazufumi²

Affiliation:

1. Division of Clinical Engineering, Sapporo Medical University Hospital

2. Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine

Publisher

Japanese Society for Medical and Biological Engineering

Subject

Computer Science Applications,Computer Vision and Pattern Recognition,Biomedical Engineering,Biomaterials,Biotechnology

Link

https://www.jstage.jst.go.jp/article/abe/6/0/6_6_88/_pdf

Reference14 articles.

1. 1. Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV: Medical Therapy For Pulmonary Arterial Hypertension. ACCP Evidence-Based Clinical Practice Guidelines. Chest. 126 Supplement (1), pp. 35S–62S, 2004.

2. 2. Galiè N, Humbert M, Vachiery J, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf AV, Beghetti M, Ghofrani A, Sanchez MAG, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J. 37(1), pp. 67–119, 2016.

3. 3. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, Kaine SF, Ivy DD, Webber SA, Rothman A, Ross RD, Aggarwal S, Takahashi M, Waldman JD: Inhaled Nitric Oxide as a Preoperative Test (INOP Test I): The INOP Test Study Group. Circulation. 106, pp. I-76–I-81, 2002.

4. 4. Malhotra R, Hess D, Lewis GD, Bloch KD, Waxman AB, Semigran MJ: Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension. Pulm Circ. 1(2), pp. 250–258, 2011.

5. 5. Ichinose F, Roberts JDJ, Zapol WM: Inhaled Nitric Oxide, A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential. Circulation. 109(25), pp. 3106–3111, 2004.